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Introduction
ART has become available in Armenia since 2005. To
evaluate progress in the response of the National Pro-
gramme to PLHIV’s needs since last evaluation time,
UNAIDS country office requested WHO/Europe HIV/
AIDS treatment and care expert for a country mission.
The purpose of the mission was to evaluate access of
PLHIV to HIV/AIDS treatment and care and other
related services.
Materials and methods
Prior to the mission some background documents had
been reviewed. During the mission key-informant inter-
views were conducted with a range of stakeholders.
Also, a focus group discussion was conducted with
PLHIV representing two NGOs. Visits were made to a
number of institutions and activities in Yerevan, the
capital.
Results
As of end 2010, cumulative 971 HIV cases were regis-
tered by the National Center for AIDS Prevention
(NCAP), 231 persons died. Of 740 PLHIV 542 (73%)
were seen for HIV care in 2010. Armenia has accepted a
higher threshold of ART initiation (CD43), as recom-
mended by recent WHO guidelines. There is no waiting
list for starting ART. By the end 2010, 250 PLHIV (46%
of seen for care) were on ART. Adherence to ART is
pretty high. Of all 294 PLHIV ever started ART, only 44
(14.9%) dropped it out. However, more than a half of
them (25) died, due to late presentation. About a quar-
ter of newly identified HIV patients had CD43at the
time of diagnosis.
Conclusions
NCAP has demonstrated high coverage with HIV care
and ART. PLHIV are satisfied with the range and quality
of services they receive. However, low level of CD4 cell
count in more than a half newly diagnosed HIV cases
(57.7% PLHIV had CD4 <350cells/mm
3 at time of diag-
nosis) in combination with the highest proportion of
PLHIV identified due to clinical symptoms compared to
other reasons for HIV testing (39.8%), indicates late pre-
sentation and raises concern of the health system’si n e f -
ficiency to diagnose HIV at early stages and thus to
early enroll in HIV care. The expert has made appropri-
ate recommendations to improve early HIV detection
for optimal care and patients’ survival.
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